PLXP
Price:
$0.087
Market Cap:
$2.53M
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores,...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-03-13
Stock Exchange
NASDAQ
Ticker
PLXP
According to PLx Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -66857020.00. This represents a change of -214.18% compared to the average of 58.55M of the last 4 quarters.
The mean historical Enterprise Value of PLx Pharma Inc. over the last ten years is 49.94M. The current -66857020.00 Enterprise Value has changed -13488.79% with respect to the historical average. Over the past ten years (40 quarters), PLXP's Enterprise Value was at its highest in in the September 2021 quarter at 436.84M. The Enterprise Value was at its lowest in in the September 2022 quarter at -7241773.10.
Average
49.94M
Median
43.65M
Minimum
1.69M
Maximum
120.05M
Discovering the peaks and valleys of PLx Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.74%
Maximum Annual Enterprise Value = 120.05M
Minimum Annual Increase = -98.32%
Minimum Annual Enterprise Value = 1.69M
Year | Enterprise Value | Change |
---|---|---|
2021 | 120.05M | 277.51% |
2020 | 31.80M | 8.75% |
2019 | 29.24M | 364.05% |
2018 | 6.30M | -79.65% |
2017 | 30.97M | 1.74% |
2016 | 1.69M | -98.32% |
2015 | 100.41M | 61.08% |
2014 | 62.34M | 2.09% |
2013 | 61.06M | 10.03% |
The current Enterprise Value of PLx Pharma Inc. (PLXP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
60.36M
5-year avg
43.67M
10-year avg
49.94M
PLx Pharma Inc.’s Enterprise Value is less than Biofrontera Inc. (3.21M), less than Guardion Health Sciences, Inc. (2.19M), less than Shuttle Pharmaceuticals Holdings, Inc. (3.88M), less than Akanda Corp. (6.01M), less than China Pharma Holdings, Inc. (6.36M), less than Cann American Corp. (1.26M), less than Acorda Therapeutics, Inc. (187.38M), less than Kala Pharmaceuticals, Inc. (10.25M), less than Mallinckrodt plc (2.62B), less than Halo Collective Inc. (15.22M), less than Alimera Sciences, Inc. (363.67M), less than China SXT Pharmaceuticals, Inc. (-7431090.00), less than Petros Pharmaceuticals, Inc. (3.44M), less than Societal CDMO, Inc. (189.40M), less than Organogenesis Holdings Inc. (347.97M), less than Lifecore Biomedical, Inc. (269.28M), less than OptiNose, Inc. (178.29M),
Company | Enterprise Value | Market cap |
---|---|---|
3.21M | $6.15M | |
2.19M | $17.02M | |
3.88M | $3.42M | |
6.01M | $2.11M | |
6.36M | $3.04M | |
1.26M | $1.26M | |
187.38M | $821.03K | |
10.25M | $27.65M | |
2.62B | $4.52M | |
15.22M | $895.00 | |
363.67M | $302.38M | |
-7431090.00 | $1.99M | |
3.44M | $3.27M | |
189.40M | $116.13M | |
347.97M | $327.46M | |
269.28M | $147.38M | |
178.29M | $143.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PLx Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PLx Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is PLx Pharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for PLx Pharma Inc. (PLXP)?
What is the 3-year average Enterprise Value for PLx Pharma Inc. (PLXP)?
What is the 5-year average Enterprise Value for PLx Pharma Inc. (PLXP)?
How does the current Enterprise Value for PLx Pharma Inc. (PLXP) compare to its historical average?